Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
UBS
Accenture
Cipla
Baxter
Daiichi Sankyo

Generated: March 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,268,489

« Back to Dashboard

Summary for Patent: 6,268,489
Title: Azithromycin dihydrate
Abstract:Non-hygroscopic, azithromycin (9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin) dihydrate and a process therefor.
Inventor(s): Allen; Douglas J. M. (New London, CT), Nepveux; Kevin M. (Old Saybrook, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:07/994,040
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,268,489
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 6,268,489

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pf Prism Cv ZMAX azithromycin FOR SUSPENSION, EXTENDED RELEASE;ORAL 050797-001 Jun 10, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050693-001 Sep 28, 1994 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050710-001 Oct 19, 1995 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pfizer ZITHROMAX azithromycin FOR SUSPENSION;ORAL 050710-002 Oct 19, 1995 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pfizer ZITHROMAX azithromycin INJECTABLE;INJECTION 050733-001 Jan 30, 1997 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pfizer ZITHROMAX azithromycin TABLET;ORAL 050711-001 Jul 18, 1996 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,268,489

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
PCT/US87/01612Jul 09, 1987

International Family Members for US Patent 6,268,489

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 44 ➤ Try a Free Trial
African Regional IP Organization (ARIPO) 8800093 ➤ Try a Free Trial
Argentina 243532 ➤ Try a Free Trial
Austria 71370 ➤ Try a Free Trial
Austria 72446 ➤ Try a Free Trial
Australia 1883988 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
US Department of Justice
Federal Trade Commission
Cantor Fitzgerald
Merck
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.